Cryopreserved Versus Liquid-Stored Platelets in Surgical Bleeding: Insights from the CLIP-II Randomized Noninferiority Trial
Highlights
- The CLIP-II trial is the first large randomized noninferiority study comparing cryopreserved platelets with conventional liquid-stored platelets for surgical bleeding control.
- Cryopreserved platelets, despite a significantly longer shelf-life, did not demonstrate noninferior hemostatic effectiveness compared to liquid-stored platelets at 24 hours post-ICU admission.
- Transfusion of cryopreserved platelets was associated with increased perioperative blood loss and greater need for additional blood product transfusions.
- Safety outcomes were comparable, but patients receiving cryopreserved platelets had longer durations of ventilation and hospital stays.
Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.